Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)

BACKGROUND: Secukinumab efficacy and retention data are emerging in patients with axial spondyloarthritis (axSpA) in real-world settings. However, limited data are available on the predictive factors that affect the retention rate. The key objective was to determine whether objective signs of inflam...

Descripción completa

Detalles Bibliográficos
Autores principales: Dougados, Maxime, Lucas, Julien, Desfleurs, Emilie, Claudepierre, Pascal, Goupille, Philippe, Ruyssen-Witrand, Adeline, Saraux, Alain, Tournadre, Anne, Wendling, Daniel, Lukas, Cédric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030893/
https://www.ncbi.nlm.nih.gov/pubmed/36921980
http://dx.doi.org/10.1136/rmdopen-2022-002802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030893/
https://www.ncbi.nlm.nih.gov/pubmed/36921980
http://dx.doi.org/10.1136/rmdopen-2022-002802

Ejemplares similares